SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-006969
Filing Date
2022-05-16
Accepted
2022-05-16 16:09:15
Documents
16
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 27501
2 EX-99.1 drma_ex991.htm EX-99.1 50990
8 drma_ex991img1.jpg GRAPHIC 3656
  Complete submission text file 0001654954-22-006969.txt   230251

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drma-20220516.xsd EX-101.SCH 5892
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20220516_lab.xml EX-101.LAB 16467
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20220516_cal.xml EX-101.CAL 898
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20220516_pre.xml EX-101.PRE 12131
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20220516_def.xml EX-101.DEF 3934
10 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 4794
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 22928968
SIC: 2834 Pharmaceutical Preparations